Inventor · disambiguated record
Wenjiang Ma
Also filed as: MA WENJIANG
1 granted patent·13 pending applications·0 citations·filing 2021–2023
1Inventor score
Files withNANJING SHIJIANG MEDICINE TECH CO LTD8SHANGHAI SHIJIANG BIOTECHNOLOGY CO LTD5NANJIANG SHIJIANG MEDICINE TECH CO LTD1
Top patents by PatentIndex Score
14 records- 0148US12502386B2Nitrogen-containing heterocyclic compound and use thereofSHANGHAI SHIJIANG BIOTECHNOLOGY CO LTD·Filed 2023·Granted Dec 23, 2025·0 cites·19 claims
- 0247US2025304608A1Phosphorus compound and use thereofSHANGHAI SHIJIANG BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 0342US2025214993A1Aromatic ring compound and use thereofSHANGHAI SHIJIANG BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 0442US2025195502A1Application of tetracyclic compound in treatment of tumorsSHANGHAI SHIJIANG BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 0540US2025282774A1Fused ring compoundSHANGHAI SHIJIANG BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 0639US2024350478A1Application of benzisoquinoline diketone compound in treatment of tumorNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2022·Application pending·0 cites
- 0739US2025120946A1Use of pyrrole compound in treatment of tumorsNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2022·Application pending·0 cites
- 0838US2024350460A1Application of hydrazide compound in tumor treatmentNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2022·Application pending·0 cites
- 0938US2025000826A1Application of benzanilide compound in tumor treatmentNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2022·Application pending·0 cites
- 1038US2025268923A1Application of tetracycline compound in treatment of tumorNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2022·Application pending·0 cites
- 1135US2024124445A1Benzene ring compound and use thereofNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2021·Application pending·0 cites
- 1235US2023404996A1Application of isoquinoline compound in tumor treatmentNANJIANG SHIJIANG MEDICINE TECH CO LTD·Filed 2021·Application pending·0 cites
- 1334US2023355647A1Marker for determining anti-cancer effects of mitochondrial oxidative phosphorylation pathway inhibitorNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2021·Application pending·0 cites
- 1432US2023098254A1Scutellariae radix compounds and use thereof for inhibiting oxidative phosphorylation pathway of mitochondriaNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wenjiang Ma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →